\n\u201cApesar de os produtos terem sido regularmente fabricados pela empresa detentora do registro do medicamento, esses lotes eram destinados a outros pa\u00edses e n\u00e3o ao Brasil\u201d, informou a nota.<\/p>\n<\/blockquote>\n
\u201cDessa forma, n\u00e3o \u00e9 poss\u00edvel garantir que tenham sido mantidas as condi\u00e7\u00f5es sanit\u00e1rias necess\u00e1rias \u00e0 conserva\u00e7\u00e3o e \u00e0 integridade do medicamento ao longo de toda a cadeia de distribui\u00e7\u00e3o at\u00e9 sua entrada no pa\u00eds, ocorrida de forma irregular\u201d, completou.<\/p>\n
Al\u00e9m da apreens\u00e3o dos lotes, a medida pro\u00edbe o armazenamento, a venda, a distribui\u00e7\u00e3o, a exporta\u00e7\u00e3o, a importa\u00e7\u00e3o, a propaganda e o transporte do produto.\u00a0<\/strong><\/p>\n\n\u201cSomente os dois lotes est\u00e3o proibidos por terem origem irregular\u201d, refor\u00e7ou a Anvisa.<\/p>\n<\/blockquote>\n
Falsifica\u00e7\u00e3o<\/h2>\n
Ainda de acordo com a ag\u00eancia, a empresa Laf Med Distribuidora de Medicamentos e Materiais Hospitalares Ltda j\u00e1 havia sido autuada por causa\u00a0da distribui\u00e7\u00e3o de medicamentos falsificados. \u201cNa ocasi\u00e3o, o caso foi encaminhado \u00e0s autoridades policiais\u201d.<\/p>\n
A Ag\u00eancia Brasil<\/strong> entrou em contato com a Laf Med Distribuidora de Medicamentos e Materiais Hospitalares Ltda. e aguarda posicionamento.<\/p>\nMedicamentos manipulados<\/h2>\n
A resolu\u00e7\u00e3o da Anvisa tamb\u00e9m determina o recolhimento de todos os medicamentos manipulados est\u00e9reis produzidos pela empresa ICT Farmac\u00eautica Ltda. no per\u00edodo de 31 de agosto a 2 de setembro de 2026. A medida suspende a venda, distribui\u00e7\u00e3o, manipula\u00e7\u00e3o e \u00a0divulga\u00e7\u00e3o dos produtos.<\/strong><\/p>\n\u201cForam constatadas defici\u00eancias cr\u00edticas nas instala\u00e7\u00f5es, utilidades, qualifica\u00e7\u00e3o de sistemas, monitoramento ambiental, processos ass\u00e9pticos, valida\u00e7\u00e3o de esteriliza\u00e7\u00e3o, filtra\u00e7\u00e3o esterilizante, integridade de recipientes e sistema de garantia da qualidade, comprometendo a garantia da esterilidade, qualidade, seguran\u00e7a e efic\u00e1cia das prepara\u00e7\u00f5es manipuladas\u201d, informou a nota.<\/p>\n
A Ag\u00eancia Brasil<\/strong> entrou em contato com a ICT Farmac\u00eautica Ltda. e aguarda posicionamento.<\/p>\n <\/p>\n
\n <\/div>\n","protected":false},"excerpt":{"rendered":"
Por EBC, A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) determinou a apreens\u00e3o de dois lotes do medicamento Ocrevus (ocrelizumabe) 300 mg\/10 ml. Os lotes s\u00e3o o H7953B14 e o H7953B06. A resolu\u00e7\u00e3o foi publicada nesta sexta-feira (25) no Di\u00e1rio Oficial da Uni\u00e3o. O Ocrevus teve o registro aprovado pela Anvisa em 2022 e \u00e9 indicado …<\/p>\n","protected":false},"author":39,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[4],"tags":[],"class_list":["post-467024","post","type-post","status-publish","format-standard","hentry","category-servicos"],"yoast_head":"\n
Anvisa pro\u00edbe lotes irregulares de medicamento para esclerose m\u00faltipla<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-09\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anvisa pro\u00edbe lotes irregulares de medicamento para esclerose m\u00faltipla\" \/>\n<meta property=\"og:description\" content=\"Por EBC, A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) determinou a apreens\u00e3o de dois lotes do medicamento Ocrevus (ocrelizumabe) 300 mg\/10 ml. Os lotes s\u00e3o o H7953B14 e o H7953B06. A resolu\u00e7\u00e3o foi publicada nesta sexta-feira (25) no Di\u00e1rio Oficial da Uni\u00e3o. O Ocrevus teve o registro aprovado pela Anvisa em 2022 e \u00e9 indicado …\" \/>\n<meta property=\"og:url\" content=\"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-09\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla\" \/>\n<meta property=\"og:site_name\" content=\"MRNews\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/eaipahpah\/?locale2=pt_BR\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-25T13:54:03+00:00\" \/>\n<meta name=\"author\" content=\"Fernando Corraa\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@conspirou\" \/>\n<meta name=\"twitter:site\" content=\"@conspirou\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fernando Corraa\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/agenciabrasil.ebc.com.br\\\/saude\\\/noticia\\\/2026-09\\\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/index.php\\\/2026\\\/09\\\/25\\\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla\\\/\"},\"author\":{\"name\":\"Fernando Corraa\",\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/#\\\/schema\\\/person\\\/2f073f2d87903a2ff9a065e41bbf17d4\"},\"headline\":\"Anvisa pro\u00edbe lotes irregulares de medicamento para esclerose m\u00faltipla\",\"datePublished\":\"2026-09-25T13:54:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/index.php\\\/2026\\\/09\\\/25\\\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla\\\/\"},\"wordCount\":461,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/#organization\"},\"articleSection\":[\"SERVI\u00c7OS\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/agenciabrasil.ebc.com.br\\\/saude\\\/noticia\\\/2026-09\\\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/index.php\\\/2026\\\/09\\\/25\\\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla\\\/\",\"url\":\"https:\\\/\\\/agenciabrasil.ebc.com.br\\\/saude\\\/noticia\\\/2026-09\\\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla\",\"name\":\"Anvisa pro\u00edbe lotes irregulares de medicamento para esclerose m\u00faltipla\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/#website\"},\"datePublished\":\"2026-09-25T13:54:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/agenciabrasil.ebc.com.br\\\/saude\\\/noticia\\\/2026-09\\\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/agenciabrasil.ebc.com.br\\\/saude\\\/noticia\\\/2026-09\\\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/agenciabrasil.ebc.com.br\\\/saude\\\/noticia\\\/2026-09\\\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/mrnews.com.br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anvisa pro\u00edbe lotes irregulares de medicamento para esclerose m\u00faltipla\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/#website\",\"url\":\"https:\\\/\\\/mrnews.com.br\\\/\",\"name\":\"MRNews\",\"description\":\"MRNews Jogos de hoje da TV, transmiss\u00f5es ao vivo, Not\u00edcias de futebol, Jogos ao vivo, Lives, resumo de novelas, Programa\u00e7\u00e3o da Globo, A Fazenda e BBB\",\"publisher\":{\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mrnews.com.br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/#organization\",\"name\":\"MRNews\",\"url\":\"https:\\\/\\\/mrnews.com.br\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/mrnews.com.br\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/MRNEws.png\",\"contentUrl\":\"https:\\\/\\\/mrnews.com.br\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/MRNEws.png\",\"width\":1254,\"height\":1254,\"caption\":\"MRNews\"},\"image\":{\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/eaipahpah\\\/?locale2=pt_BR\",\"https:\\\/\\\/x.com\\\/conspirou\",\"https:\\\/\\\/www.instagram.com\\\/eai_pahpah\",\"https:\\\/\\\/br.pinterest.com\\\/mrnewsn\\\/boards\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCacgnpznQ61fifLWr1tQ-vA?view_as=subscriber\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/#\\\/schema\\\/person\\\/2f073f2d87903a2ff9a065e41bbf17d4\",\"name\":\"Fernando Corraa\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9069acb0e588c9f4346ba747284aef18a5faaab575e89e9ccc64e315003f0b82?s=96&d=monsterid&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9069acb0e588c9f4346ba747284aef18a5faaab575e89e9ccc64e315003f0b82?s=96&d=monsterid&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9069acb0e588c9f4346ba747284aef18a5faaab575e89e9ccc64e315003f0b82?s=96&d=monsterid&r=g\",\"caption\":\"Fernando Corraa\"},\"url\":\"https:\\\/\\\/mrnews.com.br\\\/index.php\\\/author\\\/fernando-corraa\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anvisa pro\u00edbe lotes irregulares de medicamento para esclerose m\u00faltipla","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-09\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla","og_locale":"pt_BR","og_type":"article","og_title":"Anvisa pro\u00edbe lotes irregulares de medicamento para esclerose m\u00faltipla","og_description":"Por EBC, A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) determinou a apreens\u00e3o de dois lotes do medicamento Ocrevus (ocrelizumabe) 300 mg\/10 ml. Os lotes s\u00e3o o H7953B14 e o H7953B06. A resolu\u00e7\u00e3o foi publicada nesta sexta-feira (25) no Di\u00e1rio Oficial da Uni\u00e3o. O Ocrevus teve o registro aprovado pela Anvisa em 2022 e \u00e9 indicado …","og_url":"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-09\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla","og_site_name":"MRNews","article_publisher":"https:\/\/www.facebook.com\/eaipahpah\/?locale2=pt_BR","article_published_time":"2026-09-25T13:54:03+00:00","author":"Fernando Corraa","twitter_card":"summary_large_image","twitter_creator":"@conspirou","twitter_site":"@conspirou","twitter_misc":{"Escrito por":"Fernando Corraa","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-09\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla#article","isPartOf":{"@id":"https:\/\/mrnews.com.br\/index.php\/2026\/09\/25\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla\/"},"author":{"name":"Fernando Corraa","@id":"https:\/\/mrnews.com.br\/#\/schema\/person\/2f073f2d87903a2ff9a065e41bbf17d4"},"headline":"Anvisa pro\u00edbe lotes irregulares de medicamento para esclerose m\u00faltipla","datePublished":"2026-09-25T13:54:03+00:00","mainEntityOfPage":{"@id":"https:\/\/mrnews.com.br\/index.php\/2026\/09\/25\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla\/"},"wordCount":461,"commentCount":0,"publisher":{"@id":"https:\/\/mrnews.com.br\/#organization"},"articleSection":["SERVI\u00c7OS"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-09\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla#respond"]}]},{"@type":"WebPage","@id":"https:\/\/mrnews.com.br\/index.php\/2026\/09\/25\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla\/","url":"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-09\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla","name":"Anvisa pro\u00edbe lotes irregulares de medicamento para esclerose m\u00faltipla","isPartOf":{"@id":"https:\/\/mrnews.com.br\/#website"},"datePublished":"2026-09-25T13:54:03+00:00","breadcrumb":{"@id":"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-09\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-09\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-09\/anvisa-proibe-lotes-irregulares-de-medicamento-para-esclerose-multipla#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/mrnews.com.br\/"},{"@type":"ListItem","position":2,"name":"Anvisa pro\u00edbe lotes irregulares de medicamento para esclerose m\u00faltipla"}]},{"@type":"WebSite","@id":"https:\/\/mrnews.com.br\/#website","url":"https:\/\/mrnews.com.br\/","name":"MRNews","description":"MRNews Jogos de hoje da TV, transmiss\u00f5es ao vivo, Not\u00edcias de futebol, Jogos ao vivo, Lives, resumo de novelas, Programa\u00e7\u00e3o da Globo, A Fazenda e BBB","publisher":{"@id":"https:\/\/mrnews.com.br\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mrnews.com.br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/mrnews.com.br\/#organization","name":"MRNews","url":"https:\/\/mrnews.com.br\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/mrnews.com.br\/#\/schema\/logo\/image\/","url":"https:\/\/mrnews.com.br\/wp-content\/uploads\/2026\/08\/MRNEws.png","contentUrl":"https:\/\/mrnews.com.br\/wp-content\/uploads\/2026\/08\/MRNEws.png","width":1254,"height":1254,"caption":"MRNews"},"image":{"@id":"https:\/\/mrnews.com.br\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/eaipahpah\/?locale2=pt_BR","https:\/\/x.com\/conspirou","https:\/\/www.instagram.com\/eai_pahpah","https:\/\/br.pinterest.com\/mrnewsn\/boards\/","https:\/\/www.youtube.com\/channel\/UCacgnpznQ61fifLWr1tQ-vA?view_as=subscriber"]},{"@type":"Person","@id":"https:\/\/mrnews.com.br\/#\/schema\/person\/2f073f2d87903a2ff9a065e41bbf17d4","name":"Fernando Corraa","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/9069acb0e588c9f4346ba747284aef18a5faaab575e89e9ccc64e315003f0b82?s=96&d=monsterid&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9069acb0e588c9f4346ba747284aef18a5faaab575e89e9ccc64e315003f0b82?s=96&d=monsterid&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9069acb0e588c9f4346ba747284aef18a5faaab575e89e9ccc64e315003f0b82?s=96&d=monsterid&r=g","caption":"Fernando Corraa"},"url":"https:\/\/mrnews.com.br\/index.php\/author\/fernando-corraa\/"}]}},"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pa2Qf7-1XuE","amp_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/mrnews.com.br\/index.php\/wp-json\/wp\/v2\/posts\/467024","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mrnews.com.br\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mrnews.com.br\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mrnews.com.br\/index.php\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/mrnews.com.br\/index.php\/wp-json\/wp\/v2\/comments?post=467024"}],"version-history":[{"count":0,"href":"https:\/\/mrnews.com.br\/index.php\/wp-json\/wp\/v2\/posts\/467024\/revisions"}],"wp:attachment":[{"href":"https:\/\/mrnews.com.br\/index.php\/wp-json\/wp\/v2\/media?parent=467024"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mrnews.com.br\/index.php\/wp-json\/wp\/v2\/categories?post=467024"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mrnews.com.br\/index.php\/wp-json\/wp\/v2\/tags?post=467024"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}